![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Sheila Kelly
Sheila holds the post of Director, Commercial Affairs at ICON plc, a specialist clinical research organisation (CRO) that conducts clinical research on behalf of the pharmaceutical and biotechnology industries. She has 20 years’ experience in the conduct of phase II-IV clinical trials and has a special interest in data capture technologies and the implementation of customised clinical data management systems and analytical solutions.
Company:ICON plc
ICON plc is a global provider of outsourced drug development and commercialisation solutions and services to the pharmaceutical, biotechnology, medical device and government and public health organisations. The company specialises in the strategic development, management and analysis of programs that support clinical development – from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently, operates from 90 locations in 37 countries and has approximately 13,680 employees.
